EMA issues guidance document in preparation for Brexit
The European Medicines Agency (EMA) and the European Commission have published guidance to help pharma companies prepare for the UK’s withdrawal from the European Union. The first in a series of guides contains information around company location in the context of centralised procedures and certain activities, including the location of orphan designation holders, qualified persons […]
